SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: billkirn who wrote (6076)5/15/1999 12:23:00 PM
From: scaram(o)uche   of 6136
 
So everybody is going to say "goodbye", huh?

Seems like there should be a gathering point, a thread of universal interest to AGPH-prone investors, where we could go on meeting..... a "universal new bookmark" for AGPH fans.

WL? Nah.

VRTX? Seems logical to me...... who could better judge their HCV and HIV projects than a bunch of ex-AGPH freaks?

A parting comment about ethics.... D. Nichols.... thank you. You played everything close to the vest. I came to respect your bottom-line, no B.S. outlines. They gave certain of us a tad of "warm and fuzzy" during the toughest of times.

Special thanks to Margie and John Metcalf, who frequently returned, for a clear view, to that same bottom-line.

Hedge fund managers and other fear mongers..... shame on you. We're all here to make a buck, but you go too far, IMO.

Lesson learned..... two projects do not provide sufficient breadth to pipeline. One good project can get you to 10-bagger, but it takes "british biotech"-like thinking, together with a good dose of luck, to break through to independent pharma.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext